Pharmaceutical Composition for Prevention or Treatment of Post-Surgical Pain
Summary
EPO published patent application EP4084818A2 by Peptinov covering a pharmaceutical composition for preventing or treating post-surgical pain. The composition is classified under IPC codes A61K 38/17, A61K 38/20, and A61P 29/00, with inventors including Azoulai, Cassard, Salles, and Zagury. Designated states cover 31 European countries including major markets.
What changed
The EPO published patent application EP4084818A2 for a pharmaceutical composition developed by Peptinov intended for the prevention or treatment of post-surgical pain. The composition falls under therapeutic classifications related to proteins/peptides (A61K 38/17, A61K 38/20) and analgesics (A61P 29/00). The patent designates 31 European contracting states including Germany, France, Italy, Spain, and the UK.
This publication is informational regarding intellectual property rights and does not impose compliance obligations on pharmaceutical manufacturers or healthcare providers. Companies developing competing pain management therapies should review this patent for freedom-to-operate considerations. The patent grants Peptinov exclusive rights to the claimed composition in designated European states.
Source document (simplified)
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF POST-SURGICAL PAIN
Publication EP4084818A2 Kind: A2 Mar 25, 2026
Applicants
Peptinov
Inventors
AZOULAI, René, CASSARD, Xavier, SALLES, Jean-Pierre, ZAGURY, Jean-François
IPC Classifications
A61K 38/17 20060101AFI20220729BHEP A61K 38/20 20060101ALI20220729BHEP A61P 29/00 20060101ALI20220729BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.